Robert Stratta to Drug Administration Schedule
This is a "connection" page, showing publications Robert Stratta has written about Drug Administration Schedule.
Connection Strength
0.526
-
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation. Transplant Proc. 2014 Jul-Aug; 46(6):1928-31.
Score: 0.113
-
Stratta RJ, Sundberg AK, Farney AC, Rohr MS, Hartmann EL, Adams PL. Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage. Transplant Proc. 2005 Oct; 37(8):3546-8.
Score: 0.061
-
Sundberg AK, Roskopf JA, Hartmann EL, Farney AC, Rohr MS, Stratta RJ. Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation. Transplant Proc. 2005 Mar; 37(2):1294-6.
Score: 0.059
-
Stratta RJ, Alloway RR, Lo A, Hodge EE. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab. Transplant Proc. 2004 May; 36(4):1080-1.
Score: 0.056
-
Stratta RJ, Alloway RR, Lo A, Hodge E. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study. Transplantation. 2003 Apr 27; 75(8):1260-6.
Score: 0.052
-
Stratta RJ, Rohr MS, Adams PL, Sundberg AK, Hartmann EL, Armstrong G, Anderson TK, Farney AC, Roskopf JA, Hairston G, Kiger DF, Nagaraj SK, Iskandar SS, Assimos DG. Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. Clin Transpl. 2003; 229-45.
Score: 0.051
-
Stratta RJ, Alloway RR, Hodge E, Lo A. A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis. Transplant Proc. 2002 Aug; 34(5):1903-5.
Score: 0.049
-
Stratta RJ. Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1353-4.
Score: 0.037
-
Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO. Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy. Transplantation. 1989 Jan; 47(1):96-102.
Score: 0.019
-
Rogers J, Stratta RJ, Lo A, Alloway RR. Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients. Transplant Proc. 2005 Oct; 37(8):3552-4.
Score: 0.015
-
Lo A, Stratta RJ, Alloway RR, Hodge EE. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation. Transplant Proc. 2005 Mar; 37(2):1289-90.
Score: 0.015